Periodic Reporting for period 3 - Inflammostrome (Stromal cells as primary drivers of immunopathology: towards targeted disease modification in spondyloarthritis)

Over the last 2 decades, we have made a huge progress in the treatment of inflammatory diseases such as chronic arthritis by developing treatments that target immune cells and their products. A striking example of this is the major improvement in signs and symptoms of disease...